NSF SBIR/STTR Phase II + Fast-Track 2026: From $1M Phase I to $2M+ Commercialization Funding
Phase I is the discovery grant. Phase II is the real money. The startups that get the most NSF SBIR funding are not the ones with the cleanest Phase I report; they are the ones who understood the Phase II supplement ladder before they wrote their Phase I proposal. Standard Phase II is up to $1 million for 24 months. Stacked above it: a Phase IIB matching-funds supplement (commonly up to about $500,000 against qualified third-party investment), the Commercialization Readiness Pilot, and TABA technical and business assistance. Fast-Track combines Phase I and Phase II into one application for companies with mature technical and commercialization signals. This guide maps the full ladder, the Fast-Track decision, the continuous-submission windows, and a per-stage prep recipe. Want to know whether your company is closer to Phase I or already eligible for Fast-Track? Run our federal grant fit-check first. For the prequel covering NSF Phase I mechanics, see our NSF SBIR Phase I 2026 guide.
Why Phase II is the real SBIR money
Phase I is feasibility. NSF Phase I awards are typically up to about $305,000 over six to twelve months for a small technical proof-of-concept and a customer-discovery sprint. Phase I is a tryout. Phase II is the build-out. The Phase II award is structured for the work that actually produces a product: extended prototyping, pilot manufacturing or pilot deployment, regulatory pre-submission packages where relevant, customer-paid pilots, and the commercialization plan that bridges to private capital. The dollar gap between Phase I and Phase II is roughly 3x. The strategic gap is bigger than that.
- 🧪 Phase II buys scope Phase I cannot. Pilot-line tooling, contract manufacturing engagement, IP filings beyond a provisional, ISO or other regulatory groundwork, and dedicated commercial staff time. Phase I budgets do not support these.
- 🤝 Phase II is invitation-gated by Phase I success. Outside of Fast-Track, NSF only accepts Phase II proposals from companies whose Phase I project is active or recently concluded. There is no cold-applying for Phase II.
- 📈 The supplement ladder is the actual moat. Phase IIB, CRP, and TABA stack on top of Phase II. Companies that map the ladder before Phase II kickoff capture supplements other companies miss because they did not know they existed.
- 🪪 Commercialization signal is the gating filter. NSF Phase II reviewers care about technical merit and broader impact, but the deciding factor in Phase II conversion is usually the credibility of the commercialization plan: customer pipeline, market-pull letters, matching-investor signal, IP defensibility.
- 🔗 Phase II is also the bridge to non-SBIR follow-on. A successful Phase II with Phase IIB matching investors is the cleanest non-dilutive setup for a seed-to-Series-A bridge. Companies that exit Phase II without matching investors miss that bridge.
The Phase II to IIB to CRP to TABA supplement ladder
This is the headline framework of the guide. Each rung on the ladder is a separate NSF mechanism with its own eligibility trigger and its own dollar ceiling. Stacked correctly, a single Phase II awardee can plausibly access $1.5M to $2M+ of NSF capital before exiting the SBIR pipeline. Most companies leave money on the table because they treat Phase II as the end-state instead of the base of a stack.
Standard Phase II award, typically up to about $1 million over 24 months for full R&D build-out following a successful Phase I. Invitation-gated unless applied for through Fast-Track.
Supplement to an active Phase II that matches qualified third-party investment up to a published ceiling commonly around $500,000 of NSF money. Stacks on top of the base Phase II, not in place of it.
Competitive supplement among active Phase II awardees for late-stage commercialization work (pilot manufacturing, beta deployments, regulatory pre-submission). Funding levels vary per active solicitation; verify on the NSF SBIR program page.
Vendor-delivered commercialization help (market research, regulatory strategy, IP counsel, manufacturing scale-up). Cap set by SBA Policy Directive and the agency's program solicitation. Does not reduce the base R&D budget.
Fast-Track vs sequential Phase I to Phase II
Fast-Track is a combined Phase I plus Phase II application. If awarded, NSF commits Phase II funding at the time of the original decision, with Phase II disbursement triggered on Phase I milestone completion. Fast-Track collapses 12 to 18 months out of the calendar. It is also a sharper test: NSF wants substantial technical proof points and a documented commercialization story on day one, not after a Phase I tryout.
Fast-Track (combined Phase I+II)
- Eligibility
- Companies with mature technical data, prior public funding or peer-reviewed work, customer-discovery already done, and at least preliminary matching-investor or strategic-partner signal.
- Timeline
- Saves about 12 to 18 months versus sequential Phase I then Phase II. Phase II funds release on Phase I milestone completion.
- Risk
- Higher submission bar. If declined, the company has spent Fast-Track effort without falling back to a Phase I award. Resubmission as Phase I alone is allowed in a subsequent window.
- Commercialization signal
- Required up front. Letters of support from named customers or strategic partners, IP filings, market-sized TAM analysis, and a Phase IIB matching-investor narrative are effectively table stakes.
Sequential Phase I then Phase II
- Eligibility
- Open to companies with a credible technical idea, even if customer discovery and matching investors are not yet in place. Phase I is genuinely a feasibility tryout.
- Timeline
- Phase I 6 to 12 months. Phase II invited at Phase I end, with 4 to 6 months from invitation to award. Total elapsed time from initial submission to Phase II funds: roughly 18 to 24 months.
- Risk
- Lower per-application bar. Phase I results de-risk the Phase II decision for both NSF and the company. Phase II conversion is gated by Phase I performance and the commercialization plan built during Phase I.
- Commercialization signal
- Built during Phase I via the mandatory NSF customer-discovery curriculum (Beat-the-Odds Boot Camp) and optional I-Corps Teams. Letters of support assembled during Phase I.
NSF integrates I-Corps directly into the SBIR pipeline. Every Phase I awardee is required to participate in the Beat-the-Odds Boot Camp, NSF's mandatory customer-discovery training for Phase I projects. The optional I-Corps Teams program is a deeper 7-week customer-discovery curriculum that some companies use to strengthen the Phase II commercialization plan. For Fast-Track applicants, treating I-Corps Teams as a pre-application prep mechanism (run the curriculum during a prior award or as an independent academic partnership) is one of the cleanest ways to manufacture the customer-discovery evidence Fast-Track requires.
Continuous submission windows and timing
NSF SBIR moved to a continuous-submission Project Pitch model some years ago. Pitches are accepted on a rolling basis with periodic submission cutoffs for full proposals across topic areas. Phase II submissions are tied to Phase I project timelines rather than fixed agency-wide dates. The table below summarizes the typical 2026 timing pattern; verify the active solicitation on the NSF SBIR program page before planning a submission.
| Window | What submits | Topic coverage | Notes |
|---|---|---|---|
| Rolling (continuous) | Project Pitch (3-page pre-screen) | All NSF SBIR/STTR topic areas | NSF responds within about three weeks on whether the company is invited to submit a full Phase I or Fast-Track proposal. |
| ~March cutoff | Full Phase I and Fast-Track proposals | Spring cycle topic groupings | Submission requires an invitation from a successful Project Pitch. |
| ~July cutoff | Full Phase I and Fast-Track proposals | Summer cycle topic groupings | Second major full-proposal window; identical mechanics to the spring cutoff. |
| Phase I end date + invitation | Phase II proposals (sequential path) | Tied to active Phase I project | Phase II is invitation-only after Phase I; submission window opens roughly 3 to 6 months before Phase I project end-date. |
| Throughout active Phase II | Phase IIB supplement, CRP supplement, TABA supplement requests | Any active Phase II awardee | Supplements submitted through the program officer relationship and the active award mechanism, not through the open solicitation. |
The strategic implication: a company aiming for Fast-Track must have its Project Pitch in NSF's queue 4 to 6 months before the desired full-proposal cutoff, since the Pitch invitation gates the full submission. A company aiming for sequential Phase II must coordinate the Phase II submission window with the Phase I project end-date, which means thinking about Phase II in month 4 of Phase I, not month 11.
Per-stage application prep recipe
Each rung on the ladder has a different prep sequence. Treat the four cards below as the action checklist for the next 90 days of your SBIR program, not a backlog of someday work. For deeper proposal-writing fundamentals see our grant proposal writing guide and grant writing software comparison.
Phase I to Phase II transition
- Month 4 of Phase I: open the Phase II commercialization plan document; do not wait for month 9.
- Month 6: assemble a letter-of-support campaign with 5 to 10 named potential customers and 2 to 3 strategic partners.
- Month 8: complete the Beat-the-Odds Boot Camp customer-discovery outputs and convert them into Phase II narrative.
- Month 9 to 10: draft Phase II proposal, focusing technical narrative on what changed since the Phase I proposal.
- Submit Phase II in the invitation window 3 to 6 months before Phase I project end-date.
Fast-Track readiness
- Pre-application: confirm you have substantial technical proof points (often from a prior award, doctoral work, or self-funded prototyping).
- Pre-application: complete an I-Corps Teams curriculum or equivalent documented customer-discovery sprint.
- Pre-application: 8+ named customer or strategic-partner letters of support; at least one identifying a Phase IIB matching path.
- Project Pitch frame: lead with commercialization traction, not pure technical novelty. Fast-Track is decided on commercial credibility.
- If invited, draft combined Phase I+II proposal with explicit milestones gating Phase II disbursement.
Phase IIB matching-investor lineup
- Month 6 to 9 of Phase II: open a Phase IIB matching-investor pipeline; do not wait until month 18.
- Qualified-investor pool: strategic corporate partners, VC firms, customer-paid pilot contracts that NSF treats as qualified investment, and state matching programs.
- Document the matching commitment in a form NSF accepts (term sheet, signed strategic partnership, executed pilot contract).
- Coordinate the IIB submission with the program officer; supplements run through the active award mechanism.
- Verify the current matching ratio and ceiling on the NSF SBIR program solicitation before drafting.
CRP commercialization partner identification
- Identify the specific late-stage commercialization activity CRP will fund (pilot manufacturing line, regulatory pre-submission package, beta deployment).
- Identify the named commercial partner enabling the activity (contract manufacturer, regulatory consultancy, beta customer).
- Document technical traction from Phase II that justifies the late-stage activity; CRP is not for re-running early-stage prototyping.
- Coordinate the CRP supplement request with the program officer; CRP is competitive among Phase II awardees.
- Verify the current CRP solicitation on the NSF SBIR program page before assuming ceilings or eligibility.
Run your Phase II readiness check
Match your company's technical traction, customer-discovery work, and matching-investor signal against NSF's Phase II and Fast-Track expectations.
Open the readiness check →Who this applies to
NSF SBIR/STTR is deliberately broad across deep-tech sectors. Four operator archetypes capture the bulk of NSF SBIR Phase II flow.
Hardware deeptech founder
Robotics, sensors, advanced materials, or instrumentation startup with a working Phase I prototype and pilot-line manufacturing as the Phase II goal.
Biotech with FDA path
Diagnostic, device, or therapeutic-adjacent startup where Phase II funds extended preclinical or regulatory pre-submission work.
Software / AI startup
AI infrastructure, vertical-AI applications, or core-ML research with Phase II focused on pilot deployments and scaled inference.
University spin-out
Faculty-founded or postdoc-founded company licensing IP from a university tech-transfer office, with STTR (not SBIR) as the eligible mechanism due to the university partnership.
Five failure modes that kill Phase II applications
Phase II is decided on technical merit and broader impact, but most declined Phase II proposals fail on commercialization fundamentals reviewers can identify in the first ten pages. The five failures below account for a disproportionate share of Phase II declines.
Technical narrative dominates the proposal with the commercialization plan treated as an appendix. Reviewers conclude the company has not thought about customers.
Only a provisional patent on file, with no clear claim language and no FTO analysis. Reviewers cannot defend a Phase II investment if the IP can be designed around.
Phase I produced controlled-environment data but nothing closer to the deployed environment. Phase II reviewers want to see a credible scale-up path.
No named potential customers in the Phase II package, or letters of support written in vague language that signals the customer has not actually evaluated the technology.
Company exits Phase II without a Phase IIB matching investor in place and loses access to the IIB supplement entirely. Pure timing failure.
Adjacent agency Phase II analogs are worth knowing. NIH SBIR Phase II commonly ceilings around $1.7M (varies by institute) and runs on its own omnibus solicitation. DOE SBIR Phase II commonly ceilings around $1.6M against energy-mission topic areas. DOD SBIR Phase II varies widely by component (Air Force, Navy, DARPA) and uses Direct-to-Phase-II and CRP-equivalent mechanisms. For broader federal R&D funding context across agencies, see our federal grants for startups guide and complete startup grants guide. For climate-adjacent SBIR topics, see climate and clean-energy small-business grants 2026. Rural-focused R&D companies should also evaluate USDA rural business grants. SBIR awardees also need to manage federal-contractor quarterly tax posture cleanly; our friends at CeoCult cover Q2 estimated taxes for federal R&D contractors. For the operational mechanics of registering on the federal grants portals before submission, see how to use Grants.gov.
Frequently asked questions
How much is NSF SBIR Phase II in 2026?
Can you skip Phase I with NSF SBIR Fast-Track?
What is Phase IIB matching funds in NSF SBIR?
How long does NSF SBIR Phase II take from submission to award?
What is TABA in NSF SBIR?
What is the NSF Commercialization Readiness Pilot (CRP)?
Bottom line
Phase I is the discovery grant. Phase II is the real money, and the supplement ladder above it (Phase IIB matching, CRP, TABA) is where the most-prepared companies pull away from the field. Decide Fast-Track vs sequential on the basis of commercialization signal, not impatience. Open the Phase II commercialization plan in month 4 of Phase I, not month 9. Line up your Phase IIB matching investor before Phase II kickoff. And verify the current NSF SBIR program solicitation and SBA SBIR/STTR Policy Directive before assuming any specific ceiling. To match your company to the right federal program, run our federal grant finder, and for the Phase I prequel see our NSF SBIR Phase I 2026 guide.
- NSF SBIR/STTR program page (current program solicitation, Project Pitch process, Phase I and Phase II mechanics).
- SBIR.gov (federal-wide SBIR/STTR portal, historical award database, agency program comparisons).
- SBA SBIR/STTR Policy Directive (master document governing TABA caps, Phase IIB mechanics, CRP eligibility across all participating agencies).
- NSF America's Seed Fund (SBIR/STTR) (NSF-specific applicant resources, Beat-the-Odds Boot Camp, current solicitation links).
- GAO SBIR program reporting (federal-wide program evaluation and award-rate data).
- AAAS R&D Budget and Policy Program (federal R&D appropriations context for SBIR set-aside).
- NSF I-Corps program (Beat-the-Odds Boot Camp and I-Corps Teams curriculum).
- SBIR.gov award search (historical Phase I and Phase II award records by company, agency, and topic).